Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For patients with refractory acute respiratory distress syndrome (ARDS) due to COVID-19 infections, ...
Four years after ICU admission, mortality remains strikingly high in ventilated COVID-19 ARDS patients, and many survivors continue to struggle with fatigue, insomnia, functional decline, and reduced ...
Basophils, a type of white blood cell, promote recovery from acute respiratory distress syndrome (ARDS) in mice, according to researchers at Science Tokyo. In a mouse model of ARDS, basophils were ...
Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...
Drawing from research on sepsis and complement biology, they developed the monoclonal antibody vilobelimab to block overactive inflammatory responses in patients with severe inflammatory diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results